# ClinicalTrials.gov record NCT05199714

> PeptideScanner retained ClinicalTrials.gov record NCT05199714 at 2026-07-30T19:07:27.301Z. Its registry update date was 2023-10-25, and PeptideScanner's reviewed identity mapping was pramlintide.

- Evidence object: `story:clinicaltrials-gov-nct05199714-pramlintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-10-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05199714-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05199714-pramlintide-v1.json
- Content SHA-256: `b8881d1a963d10ba673b927cdf2c37d43c68d9ce0c26c52c04d02a9187118006`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT05199714 ([`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`](#source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05199714 at 2026-07-30T19:07:27.301Z. Its registry update date was 2023-10-25, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`](#source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05199714 at 2026-07-30T19:07:27.301Z. Its registry update date was 2023-10-25, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`](#source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`](#source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3))

## Sources

<a id="source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3"></a>
- **ClinicalTrials.gov record NCT05199714 · retained source version 2023-10-25:64a2c7712ab351461209406942acc1dddf6c7f48ff3796e49c72afaec0bca351** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05199714) (`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05199714." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05199714-pramlintide-v1.json SHA-256: b8881d1a963d10ba673b927cdf2c37d43c68d9ce0c26c52c04d02a9187118006.

